Quantitative structure-activity relationship (QSAR) analysis of cationic complexes of heart perfusion imaging agents and subsequent proposition of two different uptake mechanisms

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 4, 2003, Pages 505-511

  Zhang, Huabei ^a   Li, Bo ^a   Dai, Mei ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M;

ANALYTICAL PARAMETERS; ARTICLE; DRUG STRUCTURE; DRUG UPTAKE; EMPIRICISM; HEART FUNCTION; HEART PERFUSION; HUMAN; LIGAND BINDING; MATHEMATICAL MODEL; MULTIPLE REGRESSION; OXIDATION REDUCTION REACTION; PHYSICOCHEMICAL MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM CHEMISTRY; QUANTUM MECHANICS; STRUCTURE ANALYSIS;

CATIONS; HEART; HUMANS; LINEAR MODELS; MYOCARDIUM; ORGANOTECHNETIUM COMPOUNDS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TECHNETIUM;

EID: 0038737955     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702964     Document Type: Article

References (33)

1. Agrawal, V., Khadikar, P. (2002) QSAR study on nacrotic mechanism of action and toxicity: A molecular connectivity approach to Vibrio fischeri toxicity testing. Bioorg. Med. Chem. 10: 3517.
2. Chiu, K. W., Kelly, J. D., Latham, I. A. (1990) U. S. Patent: 4916214
3. Dean, R. T., Wester, D. W., Nosco, D. L. (1986) Progress in the design, evaluation and development of Tc-99m radiopharmaceuticals. In: Nocoini, M., Bandoli, G., Mazzi, U. (eds) Technetium in Chemistry and Nuclear Medicine. 2nd edn, Raven, New York, pp 148-154
4. Deutsch E., Bushong W., Glavan KA., Elder, R. C., Sodd, V. J., Scholz, K. L., Fortman, D. L., Lukes, S. J. (1981a) Heart imaging with cationic complexes of technetium. Science 214: 85-86
5. Deutsch, E., Glavan, K. A., Sodd, V. J., Nishiyama, H., Ferguson, D. L., Lukes, S. J. (1981b) Cationic Tc-99m for potential for potential myocardial imaging agents. J. Nucl. Med. 22: 897-907
6. Deutsch, E., Gerundini, P., Fanzio, F. (1988) Tc-99m agents for myocardial perfusion study. In: Spencer, R. P. (ed.) New Procedures in Nuclear Medicine. CRC Press, Boca Raton, pp 81-93
7. Diwakar, J., Wackers, F. J. T. (1993) Biokinetics of technetium-99m-tetrofosmin: Myocardial perfusion imaging agent: Implications for a one-day imaging protocol. J. Nucl. Med. 34: 1254-1597
8. Gallagher, B. M., Lebowitz, E. (1981) In: Spencer, R. P. (ed.) Radiopharmaceuticals: Structure and Activity Relationship. Grune & Stration, New York, p. 619.
9. 99mTc-Q12 in canine myocardium. Cardiology 89: 1291-1300.
10. Gerundini, P., Maffioli, L. (1989) Cationic complexes of technetium for myocardial imaging. J. Nucl. Med. 30:1415-1419
11. Gerundini, P., Savi, A., Gilardi, M. C.,Margonato, A., Vicedomini, G., Zecca, L., Hirth, W., Libson, K., Bhatia, J. C., Fazio, F. (1986) Evaluation in dogs and humans of three potential technetium-99m myocardial perfusion agents. J. Nucl. Med. 27: 409-416
12. Higley, B., Smith, F. W., Smith, T., Gemmell, H. G., Das Gupta, P., Gvozdanovic, D. V., Graham, D., Hinge, D., Davidson, J., Lahiri, A. (1993) Technetium-99m-1,2-bis[bis(2-ethoxyethyl)-phosphino]-ethane: Human biodistribution, dosimetry and safety of a new myocardial perfusion and function at rest and safety of a new myocardial perfusion imaging agent. J. Nucl. Med. 34: 30-38.
13. Iskandrian, A. S., Heo, J., Kong, B., Lyons, E., Marsch, S. (1989) Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in the coronary artery disease and comparison with coronary arteriography and exercise thallium-201 SPECT imaging. Am. J. Cardiol. 64: 270-275
14. Johnson, J. L., Abernathy, D. L. (1983) Diagnostic imaging procedure volume in the United States. Radiology 146: 851
15. Jones A. G., Abrams, M. J., Davison, A., Brodack, J. W., Toothaker, A. K., Adelstein, S. J., Kassis, A. I. (1984) Biological studies of a new class of technetium complexes: The hexakis(alkylisonitrile)-technetium(I) cations. Int. J. Nucl. Med. Biol. 11: 225-234
16. 99mTc-methoxy-isonitrile: A direct comparison in the normal individuals and patients with coronary artery disease. Circulation 79: 1282-1293
17. Kaixian, C., Jiang, H., Ji, R. (2000) Computer-Aided Drug Design. Shanghai Scientific Technology Press, Shanghai
18. Kelly, J. D., Forster, A. M., Higley, B., Archer, C. M., Booker, F. S., Canning, L. R., Chiu, K. W., Edwards, B., Gill, H. K., McPartlin, M. (1989) Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J. Nucl. Med. 34: 222-227
19. Kelly, J. D., Chiu, K. W., Latham, I. A. (1991) U. S. Patent: 5,045,302
20. Kiat, H., Maddahi, J., Roy, L. T., Van Train, K., Friedman, J., Resser, K., Berman, D. S. (1989) Comparison of technetium-99m methoxyisobutyl isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods. Am. Heart J. 117: 1-11
21. Leppo, J. A., Meerdink, D. J. (1990) Comparative myocardial extraction of two technetium-labelled BATO derivative (SQ30217, SQ32014) and thallium. J. Nucl. Med. 31: 67-74
22. Leppo, J. A., Depuey, E. G., Johnson, L. L. (1991) A review of cardiac imaging with sestamibi and teboroxime. J. Nucl. Med. 32: 2012-2022
23. Lipinski, C. A., Lombardo, F., Dominy, B. W., Feeney, P. J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46: 3-26
24. 99mTc complexes. Nucl. Med. Biol. 23: 567-584
25. Narra, R. K., Nunn, A. D., Kuczynski, B. L., Feld, T., Wedeking, P., Eckelman, W. C. (1989) A neutral technetium-99m complex for myocardial imaging. J. Nucl. Med. 30: 1830-1837
26. 99mTc]-Q12 (preliminary communication). J. Nucl. Biol. Med. 36 (Suppl.): 29-31
27. Rossetti, C., Vanoli, G., Paganelli, G., Kwiatkowski, M., Zito, F., Colombo, F., Bonino, C., Carpinelli, A., Casati, R., Deutsch, K. (994) Human biodistribution, dosimetry and clinical use of technetium(III)-99m-Q12. J. Nucl. Med. 35: 1571-1580
28. Sands, H., Delano, M. L., Gallagher, B. M. (1986) Uptake of hexakis(t-butylisonitrile) Technetium and hexakis-(isopropylisonitrile) Technetium by neonatal rat myocytes and human erythrocytes. J. Nucl. Med. 27: 404-408
29. Seldin, D. W., Johnson, L. L., Blood, D. K., Muschel, M. J., Smith, K. F., Wall, R. M., Cannon, P. J. (1989) Myocardial perfusion imaging with technetium-99m SQ30217: Comparison with thallium-201 and coronary anatomy. J. Nucl. Med. 30: 312-319
30. Stewart, R. E., Schwaiger, M., Hutchins, G. D., Chiao, P. C., Gallagher, K. P., Nguyen, N., Petry, N. A., Rogers, W. L. (1990) Myocardial clearance kinetics of technetium-99m-SQ30217: A marker of regional myocardial blood flow. J. Nucl. Med. 31: 1183-1190
31. Taillefer, R. (1992) New agents labelled with technetium-99m for myocardial perfusion imaging. Can. Assoc. Radiol. J. 43: 258-266
32. Tamaki, N., Takahashi, N., Kawamoto, M., Torizuka, T., Tadamura, E., Yonekura, Y., Okuda, K., Nohara, R., Sasayama, S., Konishi, J. (1994) Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J. Nucl. Med. 35: 594-600
33. Wackers, F. J., Berman, D. S., Maddahi, J., Watson, D. D., Beller, G. A., Strauss, H. W., Boucher, C. A., Picard, M., Holman, B. L., Fridrich, R. (1989) Technetium-99m hexakis 2-methoxyisobutyl isonitrile: Human distribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J. Nucl. Med. 30: 301-311